JAAD OnlineCOVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated
Cited by (0)
Funding sources: None.
IRB approval status: Not applicable.
Key words: COVID-19 vaccination; immune-mediated inflammatory diseases; rituximab.
Reprints not available from the authors.
© 2022 by the American Academy of Dermatology, Inc.